Navigation Links
Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced

A new class of hybrid virus that can identify, highlight and deliver genes to mice tumor cells have been developed by researchers // at the University of Texas M. D. Anderson Cancer Center. This new development, reported in the journal Cell, marks a milestone in cancer research as it could lead to novel treatment strategies for combating cancer.

As the technique increases the visibility of the cancer cells and makes it more accessible to treatment, it might allow precise monitoring of how certain anti-cancer agents work. 'In tumor-bearing mice, we show that this hybrid virus can target tumors systemically to deliver an imaging or therapeutic gene. The signal is specific only to tumors, so one can monitor drug effectiveness at the molecular level,' said Renata Pasqualini, the co-leader of the study.

The hybrid virus was created by a culmination of the biological characteristics and genetic components of an animal virus. The new hybrid virus named as AAV phage or AAVP can be used as a vehicle for delivery of specific genes targeted at tumors in mice produced through appropriate techniques.

This technique of genetically marking a tumor could eventually lead to a strategy for detection on a clinic-ready body scanner. The unique ability of the hybrid virus to deliver genes or other agents into the cells in addition to targeting specific tissues represents a distinct advantage. What surprised the researchers is that the hybrid viruses retained the properties of the parental viruses, from which they were derived.

'This is only a proof-of-concept, and although we have yet to translate these hybrid viruses for use in humans, we hope that this new system will have future clinical applications. In addition to the obvious biological interest, when the vector is refined for patient use, it could perhaps help us diagnose, monitor and treat human tumors more accurately,' said Wadih Arap, co-leader of the study.

As the n ext step, the researchers intend to design studies to evaluate the safety and efficacy of the hybrid vectors in animal models designed to mimic human models of cancer. If successful results are obtained, the research would concentrate on ways and means to adapt and optimize the AAVP-based tumor targeting for use in cancer patients.

The researchers referred to the new technique as a 'theragnostic' approach. In other words, it is a combination of the diagnostic and therapeutic modalities. With research such as this offering endless hope in the diagnosis and treatment of cancer, a cure for the disease is not very far.


'"/>




Related medicine news :

1. Molecular markers for early diagnosis of breast and ovarian cancer
2. Scientists Developed Map For Brain Molecular Communities
3. Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.
4. Molecular Flaw Detected in Aggressive Breast Cancers
5. Molecular Computer Developed To perform Calculations From Within Human Body
6. Molecular Basis Of ALS Found
7. New Molecular Treatment Identified To Treat Blood Cell Cancers
8. Researchers Find Molecular "Brake" to Cell Death
9. Solitons Could Power Molecular Electronics, Artificial Muscles
10. Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases
11. Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
Breaking Medicine Technology: